SFX by Ex Libris Inc.

Title:	The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Source:	Science [0036-8075] Viaud, Sophie yr:2013

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Iida, N. "Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment." Science 342.6161 (2013): 967-970.
description	2.	Viaud, S. "Gut microbiome and anticancer immune response: really hot Sh*t!" Cell Death and Differentiation 22.2 (2014): 199-214.
description	3.	Raber Durlacher, Judith E. "Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients." Supportive care in cancer 21.1 (2012): 343-355.
description	4.	Sengupta, P. "Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity." Proceedings of the National Academy of Sciences of the United States of America 109.28 (2012): 11294-11299.
description	5.	Aubert, X. "Analysis of the self-pulsing operating mode of a microdischarge." Plasma sources science & technology 16.1 (2007): 23-32.
description	6.	Viaud, S. "Why should we need the gut microbiota to respond to cancer therapies?" Oncoimmunology 3.1 (2014).
description	7.	Viaud S, S. "Harnessing the Intestinal Microbiome for Optimal Therapeutic Immunomodulation." Cancer research 74.16 (2014): 4217-4221.
description	8.	Bowen, J M. "Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update." Supportive care in cancer 21.1 (2012): 303-308.
description	9.	Tlaskalov-Hogenov, H. "The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases." Cellular & Molecular Immunology 8.2 (2011): 110-120.
description	10.	Iwase,, Tadayuki, T. "Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization." Nature 465.7296 (2010): 346-9.
description	11.	Abreu, Maria T. "Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function." Nature Reviews. Immunology 10.2 (2010): 131-144.
description	12.	Rakoff-Nahoum, S.. "Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis." Cell 118.2 (2004): 229-241.
description	13.	Kraal, L. "The prevalence of species and strains in the human microbiome: a resource for experimental efforts." PLoS ONE 9.5 (2014).
description	14.	Elad, S. "Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients." Supportive care in cancer 21.1 (2012): 333-9.
description	15.	Orme, Ian M M. "Current progress in tuberculosis vaccine development." Vaccine 23.17-18 (2005): 2105-8.
description	16.	Keefe, Dorothy M M. "Updated clinical practice guidelines for the prevention and treatment of mucositis." Cancer 109.5 (2007): 820-31.
description	17.	Worthington HV, H. "Interventions for preventing oral mucositis for patients with cancer receiving treatment." The Cochrane database of systematic reviews 12.4 (2007).
description	18.	Venkattraman, A. "Microscale gas breakdown: ion-enhanced field emission and the modified Paschen's curve." Journal of physics. D, Applied physics 47.50 (2014): 503001-1.
description	19.	Paraskar, A. "Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy." Nanotechnology 23.7 (2012): 75103-75103.
description	20.	Lukianova Hleb, Ekaterina Y. "Plasmonic nanobubble-enhanced endosomal escape processes for selective and guided intracellular delivery of chemotherapy to drug-resistant cancer cells." Biomaterials 33.6 (2012): 1821-1826.